Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04215198 · ClinicalTrials.gov registry record · NA
NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women
A NA study, sponsored by ESM Technologies.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT04215198 is a NA study that has completed, run by ESM Technologies. The registered enrollment target is 85 participants.
The verdict
NCT04215198, a NA study, has completed, sponsored by ESM Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
This study is intended to evaluate the effect of the dietary supplement combination of NEM® brand eggshell membrane + KD PUR® brand fish oil versus placebo in reducing exercise-induced joint pain, stiffness \& cartilage turnover in healthy men \& women. Half of the study participants will receive NEM + fish oil, once daily, orally while the other half of the study participants will receive placebo, once daily, orally while performing an exercise regimen every other day for two weeks.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Move3™ (NEM® brand eggshell membrane + KD PUR® brand fish oil)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2018-09-20 |
| Est. Completion | 2019-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04215198
The ClinicalTrials.gov registry entry for NCT04215198 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ESM Technologies, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04215198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04215198 about?
NCT04215198 is a clinical study titled "NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women". This study is intended to evaluate the effect of the dietary supplement combination of NEM® brand eggshell membrane + KD PUR® brand fish oil versus placebo in reducing exercise-induced joint pain, stiffness \& cartilage turnover in healthy men \& women. Half of the study participants will receive NE...
What is the current status of trial NCT04215198?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2018-09-20. Estimated completion is 2019-01-16.
What interventions are being tested in trial NCT04215198?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Move3™ (NEM® brand eggshell membrane + KD PUR® brand fish oil) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04215198?
This trial is sponsored by ESM Technologies, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.